1,002
Participants
Start Date
November 30, 2008
Primary Completion Date
March 31, 2009
Study Completion Date
June 30, 2009
CS-8958
CS-8958 powder 20 mg to be inhaled one time. Oseltamivir phosphate placebo capsules 2 times per day for 5 days
CS-8958
CS-8958 powder 40 mg to be inhaled one time. Oseltamivir phosphate placebo capsules 2 times per day for 5 days
oseltamivir phosphate
CS-8958 placebo powder to be inhaled one time. Oseltamivir phosphate oral capsules taken twice daily for 5 days.
Hong Kong
Tokyo
Seoul
Taipei
Lead Sponsor
Daiichi Sankyo Co., Ltd.
INDUSTRY